Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib

Detalles Bibliográficos
Autores principales: Copps, Beatrice, Lacroix, Jean-Philip, Sasseville, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029338/
https://www.ncbi.nlm.nih.gov/pubmed/32099886
http://dx.doi.org/10.1016/j.jdcr.2017.03.003
_version_ 1783499148481265664
author Copps, Beatrice
Lacroix, Jean-Philip
Sasseville, Denis
author_facet Copps, Beatrice
Lacroix, Jean-Philip
Sasseville, Denis
author_sort Copps, Beatrice
collection PubMed
description
format Online
Article
Text
id pubmed-7029338
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70293382020-02-25 Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib Copps, Beatrice Lacroix, Jean-Philip Sasseville, Denis JAAD Case Rep Case Report Elsevier 2020-02-18 /pmc/articles/PMC7029338/ /pubmed/32099886 http://dx.doi.org/10.1016/j.jdcr.2017.03.003 Text en © 2017 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Copps, Beatrice
Lacroix, Jean-Philip
Sasseville, Denis
Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
title Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
title_full Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
title_fullStr Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
title_full_unstemmed Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
title_short Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
title_sort symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029338/
https://www.ncbi.nlm.nih.gov/pubmed/32099886
http://dx.doi.org/10.1016/j.jdcr.2017.03.003
work_keys_str_mv AT coppsbeatrice symmetricaldrugrelatedintertriginousandflexuralexanthemasecondarytoepidermalgrowthfactorreceptorinhibitorgefitinib
AT lacroixjeanphilip symmetricaldrugrelatedintertriginousandflexuralexanthemasecondarytoepidermalgrowthfactorreceptorinhibitorgefitinib
AT sassevilledenis symmetricaldrugrelatedintertriginousandflexuralexanthemasecondarytoepidermalgrowthfactorreceptorinhibitorgefitinib

Ejemplares similares